Highland Capital Management, LLC Neurocrine Biosciences Inc Transaction History

Highland Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$79.65 - $106.22 $708,964 - $945,464	-8,901 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$86.18 - $99.03 $68,254 - $78,431	-792 Reduced 8.17%	8,901 $854,000
Q2 2021 Jul 30, 2021	SELL	$89.43 - $102.27 $12,162 - $13,908	-136 Reduced 1.38%	9,693 $943,000
Q1 2021 Apr 27, 2021	SELL	$87.57 - $119.4 $67,691 - $92,296	-773 Reduced 7.29%	9,829 $956,000
Q4 2020 Jan 21, 2021	SELL	$86.91 - $108.33 $49,104 - $61,206	-565 Reduced 5.06%	10,602 $1.02 Million
Q3 2020 Oct 16, 2020	BUY	$96.16 - $135.15 $1.07 Million - $1.51 Million	11,167 New	11,167 $1.07 Million
Q2 2020 Jul 22, 2020	SELL	$85.09 - $130.36 $84,239 - $129,056	-990 Reduced 8.39%	10,813 $1.32 Million
Q1 2020 May 05, 2020	BUY	$75.11 - $113.76 $886,523 - $1.34 Million	11,803 New	11,803 $1.02 Million
Q4 2019 Feb 05, 2020	SELL	$86.8 - $118.57 $855,674 - $1.17 Million	-9,858 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$83.82 - $101.5 $826,297 - $1 Million	9,858 New	9,858 $888,000
Q1 2019 Apr 18, 2019	SELL	$69.31 - $91.53 $607,294 - $801,985	-8,762 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$68.32 - $124.36 $598,619 - $1.09 Million	8,762 New	8,762 $626,000
Q3 2018 Oct 17, 2018	SELL	$98.88 - $125.85 $648,059 - $824,820	-6,554 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$75.3 - $105.99 $493,516 - $694,658	6,554 New	6,554 $644,000

654

96.5M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.4B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.